checkAd

     136  0 Kommentare Homology Medicines Announces Peer-Reviewed Publication of Five-Year Retrospective Study Conducted in Collaboration with Two PKU Key Opinion Leaders Demonstrating Substantially Elevated Phe Levels in Adults with Classical PKU on Standard of Care - Seite 3

    Company Contacts:
    Theresa McNeely
    SVP, Corporate Communications
    and Patient Advocacy
    tmcneely@homologymedicines.com
    781-301-7277
     
    Media Contact:
    Cara Mayfield
    Senior Director, Patient Advocacy
    and Corporate Communications
    cmayfield@homologymedicines.com
    781-691-3510

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Homology Medicines Announces Peer-Reviewed Publication of Five-Year Retrospective Study Conducted in Collaboration with Two PKU Key Opinion Leaders Demonstrating Substantially Elevated Phe Levels in Adults with Classical PKU on Standard of Care - Seite 3 These Data Highlight Unmet Medical Need for Therapies to Control Phe Concentrations by Targeting the Underlying Cause of PKU BEDFORD, Mass., Dec. 16, 2019 (GLOBE NEWSWIRE) - Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, …